Loading...
DOCUMENTS
84
NOTICES
152
MOTS CLES
Infliximab
Biologic drug
Epidemiology
Apre-milast
Calcium channel blockers
Ustekinumab
Azathioprine
Axial spondyloarthritis
Apremilast
Meta-Analysis
Glucocorticoids
Psoriasis
Biomédicaments
Pregnancy
Endocrine toxicity
Cardiomyopathy
Adverse side effects
Sipuleucel-T
Ethics
Anti-TNF
Bacterial rhinosinusitis
Biomarkers
Spondyloarthritis
Quality of life
Management
Autoimmune diseases
Acute Myeloid Leukaemia AML
Etanercept
Auto-Diagnostic
Addiction
Biologic
Drug reaction
Abus d'antibiotiques
Vigibase®
Beta-lactam antibiotics
Cardiotoxicity
Stability
Angiotensin receptor blockers
Antimicrobial resistance
Angiotensin-converting enzyme inhibitors
Accelerometer
Biologic therapy
Arthritis
Burden
Biological therapy
Aging
BTK protein
Arrhythmia
Anticancer drugs
Auto-immune hepatitis
Albinism
Access to care
CTLA-4
Adolescent
Sacroiliitis
ASDAS
Ankylosing
Pharmacovigilance
Alcohol
CSK tyrosine-protein kinase
Pharmacoepidemiology
Drug survival
Anti-HCV Direct Acting Antivirals DAA
Intensive care
Atrial fibrillation
Cardio-oncology
Amyloidosis
Adalimumab
Biosimilar Pharmaceuticals
Immunotherapy
Cancer
Prostate cancer
Treatment
COVID-19
Immune checkpoint inhibitors
Dermatology
Antimicrobials
Immune-related adverse events
Méta-Analyse
Anxiété
Care pathway
ArtThese
Cardiovascular risk
Psoriatic arthritis
Cardiovascular therapy
Atopic dermatitis
Antibiotic resistance
Graft-versus-host disease
Placebo
Primary adrenal insufficiency
Antimicrobiens
Autoimmunity
Alitretinoin
Antibiotic misuse
Anxiety
Biological Therapy
Antibiotics
Pharmaco-Épidémiologie
Biologics
Ankylosing spondylitis
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|